ChiCTR2200060798 版本V1.0 版本创建时间2022/06/12 10:06:02 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200060798 

最近更新日期:

Date of Last Refreshed on:

2022-06-12 10:05:53 

注册时间:

Date of Registration:

2022-06-12 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

幼年特发性关节炎早期诊断及精评估体系的研究

Public title:

A study on early diagnosis and accurate evaluation system for juvenile idiopathic arthritis

注册题目简写:

English Acronym:

研究课题的正式科学名称:

儿童免疫性疾病精准诊疗体系的建立及应用——幼年特发性关节炎早期诊断及精评估体系的研究

Scientific title:

Establishment and application of precise diagnosis and treatment system for children with immune diseases-A study on early diagnosis and accurate evaluation system for juvenile idiopathic arthritis

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

刘大玮 

研究负责人:

唐雪梅 

Applicant:

Liu Dawei 

Study leader:

Tang Xuemei 

申请注册联系人电话:

Applicant telephone:

13752837707

研究负责人电话:

Study leader's
telephone:

13012352441

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

ldw8621@163.com

研究负责人电子邮件:

Study leader's E-mail:

tangxuemei2008@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆市渝中区中山二路136号

研究负责人通讯地址:

重庆市渝中区中山二路136号

Applicant address:

No. 136, Zhongshan 2nd Road, Yuzhong District, Chongqing

Study leader's address:

No. 136, Zhongshan 2nd Road, Yuzhong District, Chongqing

申请注册联系人邮政编码:

Applicant postcode:

400014

研究负责人邮政编码:

Study leader's postcode:

400014

申请人所在单位:

重庆医科大学附属儿童医院

Applicant's institution:

Children's Hospital of Chongqing Medical University

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(2021)年伦审(临研)第(21)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

重庆医科大学附属儿童医院伦理委员会

Name of the ethic committee:

Medical Research Ethics Committee of Children's Hospital Affiliated to Chongqing Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2021-12-09 00:00:00

伦理委员会联系人:

陈诗懿

Contact Name of the ethic committee:

Chen Shiyi

伦理委员会联系地址:

重庆市渝中区中山二路136号

Contact Address of the ethic committee:

No. 136, Zhongshan 2nd Road, Yuzhong District, Chongqing

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

重庆医科大学附属儿童医院

Primary sponsor:

Children's Hospital of Chongqing Medical University

研究实施负责(组长)单位地址:

重庆市渝中区中山二路136号

Primary sponsor's address:

No. 136, Zhongshan 2nd Road, Yuzhong District, Chongqing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆医科大学附属儿童医院

具体地址:

重庆市渝中区中山二路136号

Institution
hospital:

Children's Hospital of Chongqing Medical University

Address:

136 Zhongshan 2nd Road, Yuzhong District, Chongqing

经费或物资来源:

国家十四五重点研发计划

Source(s) of funding:

National 14th Five-Year Plan for Key R&D Program

研究疾病:

幼年特发性关节炎  

Target disease:

juvenile idiopathic arthritis

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

非随机对照试验 

Study design:

Non randomized control 

研究目的:

基于多组学和生物信息学,探索幼年特发性关节炎(JIA)的诊断分型及潜在生物标志物,实现JIA早期诊断和精准分型以及个体化防治,改善疾病预后  

Objectives of Study:

To explore the diagnostic classification and potential biomarkers of juvenile idiopathic arthritis(JIA) based on multi-omics and bioinformatics, to achieve early diagnosis and accurate classification of JIA and individualized prevention and treatment, and improve disease prognosis

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

①年龄18岁以下
②确诊幼年特发性关节炎
③规律随访
④理解并签署知情同意书

Inclusion criteria

①Age less than 18 years old
②Confirmed diagnosis of juvenile idiopathic arthritis
③Regular follow-up
④Be able to understand and sign an informed consent form

排除标准:

①诊断不明确,合并出生免疫缺陷疾病,合并其他风湿免疫性疾病者
②不能够签署同意书,认知或智力障碍
③拒绝或失访

Exclusion criteria:

①Diagnosis is unclear, combined with birth immunodeficiency disease or other rheumatic immune diseases
②Inability to sign the consent form, cognitive or intellectual impairment
③Refused or lost visits

研究实施时间:

Study execute time:

From 2022-07-01 00:00:00 To 2026-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-07-01 00:00:00 To 2026-12-31 00:00:00

干预措施:

Interventions:

组别:

连续入组

样本量:

2200

Group:

case series

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆医科大学附属儿童医院 

单位级别:

三甲 

Institution
hospital:

Children's Hospital of Chongqing Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

江苏省 

市(区县):

南京市 

Country:

China

Province:

Jiangsu

City:

Nanjing

单位(医院):

江苏省南京市儿童医院 

单位级别:

三甲 

Institution
hospital:

Nanjing Children's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广东 

市(区县):

深圳 

Country:

China

Province:

Guangdong

City:

Shenzhen

单位(医院):

深圳市儿童医院 

单位级别:

三甲 

Institution
hospital:

Shenzhen Children's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

浙江 

市(区县):

杭州 

Country:

China

Province:

Zhejiang

City:

Hangzhou

单位(医院):

浙江大学医学院附属儿童医院 

单位级别:

三甲 

Institution
hospital:

The Children's Hospital of Medical School of Zhejiang University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

中国医学科学院北京协和医院 

单位级别:

三甲 

Institution
hospital:

Peking Union Medical College Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖南 

市(区县):

长沙 

Country:

China

Province:

Hu'nan

City:

Changsha

单位(医院):

中南大学湘雅二医院 

单位级别:

三甲 

Institution
hospital:

The Second Xiangya Hospital of Central South University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京儿童医院 

单位级别:

三甲 

Institution
hospital:

Beijing Children's Hospital, Capital Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京大学第三医院 

单位级别:

三甲 

Institution
hospital:

The Third Hospital of Peking University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

神州医疗科技股份有限公司 

单位级别:

其他 

Institution
hospital:

Digital China Medical Technology Co., Ltd.

Level of the institution:

测量指标:

Outcomes:

指标中文名:

细胞因子

指标类型:

主要指标

Outcome:

cytokines

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

细胞亚群

指标类型:

主要指标

Outcome:

cell subpopulations

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

幼年特发性关节炎分型

指标类型:

主要指标

Outcome:

classification of juvenile idiopathic arthritis

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 0 years
最大 Max age 18 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

非随机对照试验

Randomization Procedure (please state who generates the random number sequence and by what method):

NO RCT study

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不公开

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

No pubilc

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF和EDC及课题组设计并参与构建的幼年特发性关节炎专病数据库

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF, EDC, and the database of juvenile idiopathic arthritis designed by our research team

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-06-12 10:05:53